Raaj Medisafe India Ltd has closed its trading window for all promoters, directors, officers, designated employees, and their immediate relatives effective July 1, 2026. This measure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The restriction will remain in force until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026.

The company stated that the specific date for the Board Meeting to declare these results will be communicated in due course. The trading window closure is a standard procedural step implemented to prevent insider trading during the period leading up to financial disclosures.

Key Details

The notice was signed by Arpit Bangur, Managing Director, on June 19, 2026.

Raaj Medisafe India Limited's board has approved the audited financial results for the quarter and year ended March 31, 2026. The meeting, held on May 29, 2026, also authorized the submission of financial statements and related party transactions to BSE.

The board approved the financial statements and cash flow statement for the year ended March 31, 2026. Additionally, the directors considered and approved transactions with related parties entered into by the company between October 1, 2025, and March 31, 2026.

The board also took note of the draft auditors' report on the financial statements for the year ended March 31, 2026. The audited financial results, cash flow statement, and statement of assets and liabilities as of March 31, 2026, were taken on record and authorized for submission to the exchange.

Other key approvals included the integrated finance report for the quarter and year ended March 31, 2026. This report includes particulars of related party transactions and a statement on the utilization of funds raised through preferential allotment.

The board authorized the registrar and transfer agent (RTA) to direct the conversion of physical shares to demat form as per a SEBI circular dated January 30, 2026. The reconciliation of share capital audit for the quarter ended March 31, 2026, was also adopted.

The shareholding pattern and the integrated governance report, which includes the investor grievance and redressal report for the quarter ended March 31, 2026, were taken on record.